These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 3098544

  • 1. Aldose reductase inhibitors and late complications of diabetes.
    Benfield P.
    Drugs; 1986; 32 Suppl 2():43-55. PubMed ID: 3098544
    [Abstract] [Full Text] [Related]

  • 2. Aldose reductase inhibitors in clinical practice. Preliminary studies on diabetic neuropathy and retinopathy.
    Pitts NE, Gundersen K, Mehta DJ, Vreeland F, Shaw GL, Peterson MJ, Collier J.
    Drugs; 1986; 32 Suppl 2():30-5. PubMed ID: 3098543
    [Abstract] [Full Text] [Related]

  • 3. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors.
    Jacobson M, Sharma YR, Cotlier E, Hollander JD.
    Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1426-9. PubMed ID: 6413448
    [Abstract] [Full Text] [Related]

  • 4. Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil.
    Sima AA, Bril V, Nathaniel V, McEwen TA, Brown MB, Lattimer SA, Greene DA.
    N Engl J Med; 1988 Sep 01; 319(9):548-55. PubMed ID: 3136331
    [Abstract] [Full Text] [Related]

  • 5. Recent advances in the therapy of diabetic peripheral neuropathy by means of an aldose reductase inhibitor.
    Greene DA, Lattimer SA.
    Am J Med; 1985 Nov 15; 79(5A):13-7. PubMed ID: 3000175
    [Abstract] [Full Text] [Related]

  • 6. Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil.
    Beyer-Mears A, Ku L, Cohen MP.
    Diabetes; 1984 Jun 15; 33(6):604-7. PubMed ID: 6427041
    [Abstract] [Full Text] [Related]

  • 7. Clinical experience with sorbinil--an aldose reductase inhibitor.
    Pitts NE, Vreeland F, Shaw GL, Peterson MJ, Mehta DJ, Collier J, Gundersen K.
    Metabolism; 1986 Apr 15; 35(4 Suppl 1):96-100. PubMed ID: 3083213
    [Abstract] [Full Text] [Related]

  • 8. The effect of an aldose reductase inhibitor (Sorbinil) on diabetic neuropathy and neural function of the retina: a double-blind study.
    Christensen JE, Varnek L, Gregersen G.
    Acta Neurol Scand; 1985 Feb 15; 71(2):164-7. PubMed ID: 3920861
    [Abstract] [Full Text] [Related]

  • 9. Effects of sorbinil therapy in diabetic patients with painful peripheral neuropathy and autonomic neuropathy.
    Jaspan JB, Herold K, Bartkus C.
    Am J Med; 1985 Nov 15; 79(5A):24-37. PubMed ID: 3000176
    [Abstract] [Full Text] [Related]

  • 10. Aldose reductase inhibition in diabetic neuropathy: clinical and neurophysiological studies of one year's treatment with sorbinil.
    O'Hare JP, Morgan MH, Alden P, Chissel S, O'Brien IA, Corrall RJ.
    Diabet Med; 1988 Sep 15; 5(6):537-42. PubMed ID: 2974776
    [Abstract] [Full Text] [Related]

  • 11. Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil.
    Tomlinson DR, Moriarty RJ, Mayer JH.
    Diabetes; 1984 May 15; 33(5):470-6. PubMed ID: 6202576
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition.
    Gillon KR, Hawthorne JN, Tomlinson DR.
    Diabetologia; 1983 Oct 15; 25(4):365-71. PubMed ID: 6416913
    [Abstract] [Full Text] [Related]

  • 16. Clinical studies with an aldose reductase inhibitor in the autonomic and somatic neuropathies of diabetes.
    Jaspan JB, Towle VL, Maselli R, Herold K.
    Metabolism; 1986 Apr 15; 35(4 Suppl 1):83-92. PubMed ID: 3083212
    [Abstract] [Full Text] [Related]

  • 17. [Clinical application of aldose reductase inhibitors--prevention and therapy of diabetic complications].
    Hotta N, Sakamoto N.
    Nihon Rinsho; 1987 Dec 15; 45(12):3010-27. PubMed ID: 3128677
    [No Abstract] [Full Text] [Related]

  • 18. The effect of aldose reductase inhibition on motor nerve conduction velocity in diabetic rats.
    Yue DK, Hanwell MA, Satchell PM, Turtle JR.
    Diabetes; 1982 Sep 15; 31(9):789-94. PubMed ID: 6819173
    [Abstract] [Full Text] [Related]

  • 19. NIH conference. Aldose reductase and complications of diabetes.
    Cogan DG, Kinoshita JH, Kador PF, Robison G, Datilis MB, Cobo LM, Kupfer C.
    Ann Intern Med; 1984 Jul 15; 101(1):82-91. PubMed ID: 6203454
    [Abstract] [Full Text] [Related]

  • 20. Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor.
    Beyer-Mears A, Cruz E.
    Diabetes; 1985 Jan 15; 34(1):15-21. PubMed ID: 3917257
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.